Tolerability and effects of OROS® MPH (Concerta ®) on functioning, severity of disease and quality of life in children and adolescents with ADHD: results from a prospective, non-interventional trial (Q42745025)
Jump to navigation
Jump to search
scientific article published on 6 August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tolerability and effects of OROS® MPH (Concerta ®) on functioning, severity of disease and quality of life in children and adolescents with ADHD: results from a prospective, non-interventional trial |
scientific article published on 6 August 2009 |
Statements
1 reference
Tolerability and effects of OROS® MPH (Concerta ®) on functioning, severity of disease and quality of life in children and adolescents with ADHD: results from a prospective, non-interventional trial (English)
1 reference
Martin Gerwe
1 reference
Kirsten Stollhoff
1 reference
Jacek Mossakowski
1 reference
Hans-Juergen Kuehle
1 reference
Ulrich Goertz
1 reference
Christopher Schaefer
1 reference
Manuela Bogdanow
1 reference
Steffen Heger
1 reference
6 August 2009
1 reference
1 reference
1
1 reference
2
1 reference
175-186
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference